platelet counts

Related by string. platelet count * Platelets . Platelet . platelets : platelet rich . platelet derived growth . human platelet derived . donating platelets . platelet activation . platelet inhibition . platelet clumping / counting . counted . Counting . Count . Counter . counter : Counter Bulletin Board . Christmas Bird Count . Iraq Body Count . Counter Strike . Counting Crows . Vote Count * *

Related by context. All words. (Click for frequent words.) 75 platelet count 66 serum sodium 65 serum phosphate 64 neutrophil counts 63 neutrophil count 63 hemoglobin concentrations 63 serum creatinine levels 62 viral load 62 serum calcium levels 62 serum potassium 62 hemoglobin levels 61 serum testosterone 61 serum calcium 61 lymphocyte counts 61 antibody titers 61 hemoglobin concentration 61 serum urate 61 viral loads 61 HBV DNA levels 61 nephrotoxicity 60 platelet 60 Hb levels 60 HIV RNA 60 alanine aminotransferase 60 severe neutropenia 60 plasma concentrations 60 leukocytosis 60 paraprotein 59 CD4 + cell 59 CD4 counts 59 febrile neutropenia 59 viremia 59 viral suppression 59 aspartate aminotransferase 59 hematologic toxicity 59 platelet reactivity 58 lactate dehydrogenase LDH 58 elevated creatinine 58 serum phosphate levels 58 fosamprenavir 58 granulocyte 58 sUA 58 LEXIVA 58 endogenous EPO 58 PSA nadir 58 serum HBV DNA 58 thrombocytopenia 58 serum urate levels 58 creatinine levels 58 HBV DNA 58 A1C levels 58 serum creatinine 58 hemoglobin Hb 57 HBeAg seroconversion 57 urate levels 57 CD4 cell 57 serum phosphorus levels 57 serum uric acid 57 reticulocytes 57 HCV RNA 57 alanine aminotransferase ALT 57 LVEF 57 grade glioma 57 CMV infection 57 ng dL 57 proteinuria 57 sUA levels 57 virologic response 57 iPTH 57 leukocyte count 57 aspartate aminotransferase AST 57 renal function 57 HbA1c levels 57 alkaline phosphatase 57 blood Phe levels 57 serum IGF 57 seropositive patients 57 Hb 57 myelosuppression 57 dose cohorts 57 cytopenias 57 seroconversion 56 biochemical relapse 56 serum albumin 56 hemolysis 56 hyperphenylalaninemia HPA due 56 pulmonary exacerbations 56 fluvastatin 56 paricalcitol 56 plasma HCV RNA 56 decitabine 56 glomerular filtration 56 thyroid stimulating hormone 56 serum aminotransferase levels 56 undetectable viral loads 56 CD4 + 56 HbF 56 specific antigen PSA 56 imatinib therapy 56 virological response 56 creatinine clearance 56 hypomagnesemia 56 PROMACTA 56 titers 56 hemoglobin 56 mg BID 56 liver enzymes 56 Hgb 56 chlorambucil 56 CD4 + cells 56 hsCRP levels 56 lactate dehydrogenase 56 PSADT 56 leukopenia 56 creatine kinase 56 serum LDL cholesterol 56 serum ALT 56 lymphopenia 56 neutrophil 56 purpura ITP 55 azacitidine 55 cells/mm3 55 CD4 + T 55 serum glucose 55 mEq L 55 blood phenylalanine Phe 55 serum potassium levels 55 immune reconstitution 55 steroid dexamethasone 55 Neutropenia 55 serum concentrations 55 cells μL 55 ertapenem 55 liver histology 55 CLL cells 55 splenectomized patients 55 Thrombocytopenia 55 IFN α 55 DAPT 55 mg/m2 dose 55 eGFR 55 inflammatory lesions 55 RBC transfusions 55 dose ritonavir 55 elevated bilirubin 55 #mg/m# [002] 55 serum PTH 55 gout flares 55 neutropenia dehydration dyspnea 55 hypercalcemia 55 lymphocytosis 55 intravascular hemolysis 55 sweat chloride 55 thrombotic events 55 pg mL 55 serum prostate 55 plasma uric acid 55 serum HCV RNA 55 serum phosphorus 55 virologic failure 55 serum sodium levels 55 antibody responses 55 TNF antagonist 55 serum magnesium 55 LDL C 55 acute GvHD 55 plasma pharmacokinetics 55 platelet transfusions 55 leukocyte 55 serum bicarbonate 55 vWF 55 virological suppression 55 rFVIIa 55 bilirubin levels 55 LEXIVA r 55 platelet inhibition 55 complete remissions 55 eculizumab therapy 55 cells mcL 55 atazanavir 55 FVIII 55 CD4s 54 HbA 1c levels 54 Hemolysis 54 creatinine 54 nicardipine 54 Nplate 54 4mg/kg 54 CK MB 54 ritonavir boosted 54 HDL C 54 #.#ng/ml 54 IgA 54 calcitonin 54 posaconazole 54 haematological toxicity 54 platelet aggregation 54 dose cyclophosphamide 54 pleural fluid 54 HSCT 54 serum cortisol 54 immune thrombocytopenic purpura 54 aminotransferase levels 54 kidney function 54 blood Phe 54 hypotensive 54 lymphocytes 54 serum clusterin levels 54 autoantibody levels 54 μg ml 54 PNH patients 54 mL/min/#.# m 2 54 bone marrow suppression 54 glycated hemoglobin levels 54 dose limiting toxicities 54 gastric pH 54 pegfilgrastim 54 coadministration 54 renal dysfunction 54 AST ALT 54 transaminase levels 54 transaminases 54 QTcF 54 dose cohort 54 cytogenetic responses 54 glycosylated hemoglobin HbA1c 54 aminotransferases 54 thrombocytosis 54 prolonged QT interval 54 bronchodilation 54 intracranial hemorrhage ICH 54 urinary oxalate 54 evaluable subjects 54 Telintra 54 grade gliomas 54 plasma viremia 54 left ventricular ejection 54 sustained virologic response 54 tipranavir 54 albuminuria 54 lymphocyte count 54 leucopenia 54 adrenal suppression 54 certolizumab 54 mg kg dose 54 platelets 54 serum testosterone levels 54 lopinavir 54 anti leukemic 54 RBC folate 54 corticosteroid dose 54 CD4 cells 54 B7 H3 54 renal toxicity 54 serum cholesterol 54 nmol L 54 dosage regimens 54 lumbar spine BMD 53 CD4 T 53 undetectable viral load 53 systemic toxicity 53 engraftment 53 D dimer 53 retinal thickness 53 plasma urate 53 azacytidine 53 posttransplant 53 NATRECOR ® 53 IFN beta 53 dosing frequency 53 mucosal healing 53 amprenavir 53 hydroxyurea 53 symptomatic intracranial 53 adiponectin levels 53 bilirubin 53 thromboembolic events 53 leukemia AML 53 thrombocytopenic patients 53 recurrent VTE 53 HIV HCV coinfected 53 macroalbuminuria 53 BH4 53 severe exacerbations 53 CIN3 53 eosinophilia 53 topotecan 53 intramuscularly 53 transaminase elevations 53 eosinophil count 53 plasma triglycerides 53 neutropenic patients 53 serum phosphorous 53 chronic eosinophilic leukemia 53 tirofiban 53 virologic suppression 53 thyroxine 53 thyroglobulin 53 transgene expression 53 homocysteine concentrations 53 relapsed MM 53 hemodialysis patients 53 CD4 lymphocyte count 53 adefovir 53 IU ml 53 Pegasys plus Copegus 53 palifermin 53 tacrolimus 53 plasma leptin 53 ribavirin therapy 53 aminotransferase ALT 53 HBeAg positive 53 CsA 53 anti Xa 53 REYATAZ r arm 53 parathyroid hormone 53 anticoagulation 53 RBP4 53 romiplostim 53 dose dexamethasone 53 Doxil ® 53 cells uL 53 granulocytes 53 levodopa therapy 53 hemodilution 53 Hb A1C 53 elevated ALT 53 SGPT 53 imatinib 53 anti dsDNA antibodies 53 intraocular pressure IOP 53 intra ocular pressure 53 β blocker 53 peginterferon 53 dose cytarabine 53 Toxicities 53 microglial activation 53 ascending dose 53 urinary protein 53 CD4 + CD# 53 circulating lymphocytes 53 PASI scores 53 vitamin D metabolites 53 pCR 53 corticosteroid therapy 53 hENT1 53 tolvaptan 53 metastatic malignant 53 #mg/m# [001] 53 uric acid levels 53 IFN gamma 53 hyperammonemia 53 SCr 53 left ventricular systolic 53 hyperkalemia 53 moderate renal impairment 53 HCV genotype 1 53 leukocyte counts 53 non splenectomized 53 NPH insulin 53 rapid virologic response 53 ATACAND 53 #mmHg [001] 53 cytogenetic response 53 copies mL 53 low dose ritonavir 53 daunorubicin 53 peripheral blood mononuclear 52 density lipoprotein cholesterol HDL 52 concomitant antibiotics 52 inotropic 52 interferon alfa 2b 52 heavily pretreated patients 52 irbesartan 52 estimated glomerular filtration 52 Ribavirin causes 52 bone resorption 52 orthostatic hypotension 52 Lupuzor ™ 52 thrombotic complications 52 C1 INH 52 dose colchicine 52 thyrotropin 52 Myelosuppression 52 mycophenolate mofetil 52 vascularization 52 undetectable viral 52 TPV r 52 hypertensive patients 52 postoperative mortality 52 nmol liter 52 asymptomatic carotid stenosis 52 apo B 52 symptomatic VTE 52 symptomatic hypotension 52 blood glucose concentrations 52 weekly subcutaneous injections 52 PROCRIT 52 p# activation 52 plus methotrexate 52 factor G CSF 52 tumor regression 52 metabolic acidosis 52 CrCl 52 chloride secretion 52 epoetin alfa 52 CLL SLL 52 lopinavir r 52 elevated serum creatinine 52 parasitemia 52 Retreatment 52 HbA1c 52 PREZISTA r 52 elevated blood glucose 52 lamivudine refractory patients 52 cTnT 52 intraocular pressure 52 viral titer 52 etanercept 52 fasting glucose levels 52 HBeAg negative 52 immunosuppression 52 erythropoiesis 52 EXJADE 52 myeloperoxidase 52 definite stent thrombosis 52 bleomycin 52 EDSS scores 52 troponins 52 nanomolar 52 docetaxel chemotherapy 52 DLTs 52 Asymptomatic 52 triiodothyronine 52 nadir CD4 cell 52 dexamethasone Decadron 52 Cmax 52 factor GCSF 52 severe hypoglycemic 52 complete cytogenetic response 52 mRCC 52 peptide BNP 52 thrombocytopenic 52 undetectable HCV RNA 52 plasma glucose 52 undetectable HBV DNA 52 aldosterone 52 baseline CD4 52 vascular permeability 52 liver enzyme 52 myelodysplastic syndromes MDS 52 grade cervical intraepithelial 52 plasma folate 52 preserved ejection fraction 52 cTnI 52 blood glucose levels 52 alpha 2a 52 nilotinib 52 #mg dose [001] 52 insulin detemir 52 glomerular filtration rate 52 mcg mL 52 albumin excretion 52 troponin T 52 Exacerbations 52 tryptase 52 A1c levels 52 G CSF 52 CD# upregulation 52 VAPRISOL 52 timepoint 52 cyclosporine 52 sulfasalazine 52 microliter 52 sunitinib 52 elevated LDH 52 elevated troponin 52 neovascular 52 mIU L 52 hemoglobin hematocrit 52 hemoglobin Hb levels 52 β blockers 52 microvascular complications 52 elevated intraocular pressure 52 systemic bioavailability 52 vWD 52 ACh 52 PBMCs 52 BMPR2 52 AZT zidovudine Retrovir 52 Pharmacokinetics PK 52 renal insufficiency 52 homocysteine levels 52 systolic dysfunction 52 enlarged spleens 52 varices 52 myopathy rhabdomyolysis 52 hepatocellular carcinomas 52 salivary flow 52 dose clopidogrel 52 metastatic lesions 52 K ras mutations 52 intracranial pressure 52 galiximab 52 bezafibrate 52 antiretroviral naive 52 g dL 52 NAbs 52 argatroban 52 troponin 52 concentration Cmax 52 serum TSH 52 median CD4 52 nelfinavir 52 neutropenic 52 CMV disease 52 hepatorenal syndrome 52 neointimal hyperplasia 52 bcr abl 52 ejection fractions 51 artery stenosis 51 alteplase 51 LHRH agonists 51 pharmacokinetic PK profile 51 beta blocker therapy 51 proliferative diabetic retinopathy 51 timepoints 51 mg/m2 51 teriflunomide 51 Dasatinib 51 favorable pharmacokinetic profile 51 GnRH agonist 51 Ejection Fraction 51 alemtuzumab treated 51 aPTT 51 administered subcutaneously 51 serum homocysteine 51 density lipoprotein HDL cholesterol 51 transaminase 51 lipid elevations 51 CLA supplementation 51 riociguat 51 tumor lysis syndrome 51 candidemia 51 nucleotide analog 51 myeloproliferative diseases 51 bFGF 51 androgen deprivation 51 dose Iluvien 51 TMC# r 51 hA# 51 NT proBNP concentrations 51 hydroxyvitamin D levels 51 hemoglobin A1c HbA1c 51 lanthanum carbonate 51 atazanavir ritonavir 51 LDL cholesterol 51 hepatic function 51 Peginterferon 51 virological failure 51 ximelagatran 51 Pegasys ® 51 ruboxistaurin 51 explants 51 mcg kg 51 serum PSA 51 immunoreactivity 51 dosing regimens 51 gastrointestinal stromal tumors GIST 51 atherogenic lipids 51 prednisone prednisolone 51 ^ sup #m 51 allopurinol 51 adrenal function 51 Hydroxyurea 51 interferon 51 lymphocyte 51 ApoA1 51 haematologic 51 locoregional disease 51 hypercholesterolaemia 51 hypophosphatemia 51 Fludara 51 virologic 51 mixed hyperlipidemia 51 neutrophils 51 FOLFOX4 51 viral kinetics 51 Lp PLA2 51 tiotropium 51 dosing cohort 51 serum CRP 51 hs CRP 51 mg doses 51 Serum creatinine 51 ng ml 51 rt PA 51 Gleevec resistant 51 lopinavir r arm 51 reinfarction 51 urinary N telopeptide 51 urinary excretion 51 transferrin saturation 51 clinically insignificant 51 TMP SMX 51 p = #.# [003] 51 antiviral activity 51 serum uric acid sUA 51 idraparinux 51 enzyme elevations 51 glycemia 51 ejection fraction 51 FOLPI 51 fumagillin nanoparticles 51 serum bilirubin 51 agents ESAs 51 baseline LDH 51 hematologic disorders 51 SMN protein 51 immunological responses 51 HBeAg 51 alanine transaminase 51 NSAID therapy 51 pyrazinamide 51 FOXP3 51 Akt activation 51 biochemical recurrence 51 Forodesine HCl 51 CD# + [002] 51 dose melphalan 51 hypoperfusion 51 OADs 51 Decitabine 51 FEV1 51 SGOT 51 triglyceride levels 51 μmol L 51 penetrance 51 pT3 51 oblimersen 51 activated partial thromboplastin 51 neutralizing antibody 51 Natalizumab 51 virologic responses 51 hepatocellular 51 adjunctive placebo 51 intravenous bisphosphonates 51 ADHF 51 antigen PSA levels 51 chronic HCV 51 baseline HbA1c 51 basal cell nevus syndrome 51 serum vitamin D 51 hypotension 51 CCyR 51 homozygous familial hypercholesterolemia 51 CMV reactivation 51 plasma renin 51 APTIVUS r 51 μg liter 51 Molecular Weight Heparin 51 platelet function 51 bosentan 51 intravenous cyclophosphamide 51 CIMZIA TM 51 graft occlusion 51 acute STEMI 51 ischemic cardiomyopathy 51 tissue oxygenation 51 pancytopenia 51 dose interleukin 51 subcutaneous dose 51 pyridostigmine 51 complete cytogenetic 51 ZOLINZA 51 protein excretion 51 parasitaemia 51 serum retinol 51 hypertensives 51 hemorrhagic complications 51 Bortezomib 51 copies ml 51 metastatic malignant melanoma 51 mIU mL 51 hematological parameters 51 pg ml 51 triglyceride concentrations 51 exacerbations 51 coagulopathy 51 cART 51 von Willebrand factor 51 MP4OX 51 candesartan cilexetil 51 liver transaminases 51 insulin degludec 51 XIENCE V PROMUS Stent 51 pioglitazone 51 PegIFN RBV 51 cerebrospinal fluid CSF 51 systemic corticosteroids 51 titer 51 prothrombin 51 nucleoside analog 51 thromboembolic complications 51 mm Hg systolic 51 antitumor activity 51 liver enzymes ALT 51 bad cholesterol LDL 51 #mg BID [003] 51 annualized relapse 51 hemodynamically 51 neutropenia 51 mcg BID 51 anthracycline therapy 51 antibody titer 51 leukocytes 51 infarct size 51 HAART regimen 51 creatine kinase MB 51 plasma creatinine 51 progression TTP 51 IL 1ß 51 peginterferon alfa 51 systemic amyloidosis 51 VZV 51 urate lowering therapy 51 #μg [001] 51 hepatic enzymes 51 cerebral ischemia 51 bone marrow reticulin 51 mg dL 51 #.#/#.# mmHg [001] 51 cinacalcet 51 hemolytic anemia 50 fibrin deposition 50 Valcyte 50 Vacc 4x 50 leucovorin 50 neurologic outcomes 50 Non inferiority 50 CD4 50 laboratory abnormalities 50 Inhibin B 50 prolactin levels 50 elvitegravir 50 fibrinolysis 50 aldosterone antagonist 50 FOLFIRI 50 haemolysis 50 preoperative PSA 50 8mg/kg 50 mg dose 50 endophthalmitis 50 virologic breakthrough 50 pulmonary artery pressure 50 neurologic progression 50 adalimumab 50 urinary cortisol 50 rituximab 50 rtPA 50 imipenem 50 KRAS mutations 50 ALT elevations 50 HbA 1C 50 plus ribavirin 50 hsCRP 50 recurrent UTI 50 hyperoxia 50 hematocrit 50 esophageal carcinoma 50 viraemia 50 thrombolytic agents 50 concomitant medications 50 umol L 50 BENICAR HCT 50 nodular partial response 50 CR CRu 50 FluCAM 50 intravesical 50 Th2 cytokines 50 SUVmax 50 lung function 50 INCB# [003] 50 Immunohistochemical analysis 50 severe hypersensitivity reactions 50 autoantibody positive 50 severe rotavirus gastroenteritis 50 postoperative complication 50 systemic hypotension 50 bioavailable testosterone 50 therapeutic regimens 50 ascending doses 50 mutated KRAS 50 intermittent dosing 50 immunosuppressive agents 50 tipranavir r 50 g dl 50 clodronate 50 nonvertebral fractures 50 leukopenia neutropenia 50 tumor regressions 50 Elitek 50 urine NGAL 50 intramuscular dose 50 osmolality 50 calcitriol 50 antitumor efficacy 50 lamivudine 50 EDSS score 50 SSc patients 50 enoxaparin 50 Factor IX 50 interferon therapy 50 hypocalcemia 50 benazepril 50 hypogonadal men 50 LDL cholesterol levels 50 hypoxemia 50 upper gastrointestinal bleeding 50 TNFalpha 50 receiving immunosuppressive therapy 50 REYATAZ r 50 oxygen desaturation 50 tumoral 50 SERCA2a 50 ULORIC 50 MADRS score 50 antiviral efficacy 50 methacholine 50 raltegravir 50 log# 50 invasive aspergillosis 50 blood platelets 50 oral allopurinol 50 dalteparin 50 HBeAg negative patients 50 docetaxel Taxotere ® 50 #mg BID [001] 50 deferasirox 50 adrenomedullin 50 IV bisphosphonates 50 aminotransferase 50 follicle stimulating hormone FSH 50 taxane chemotherapy 50 dexamethasone 50 periprocedural 50 #.#mg/dL 50 mcg dose 50 T2DM 50 indinavir 50 mcL 50 hepatotoxicity 50 ADPKD 50 cardiac biomarkers 50 arterial thromboembolic events 50 histologically 50 TNF α 50 acute humoral rejection 50 thyrotropin levels 50 grade dysplasia 50 cystatin C 50 glomerular 50 nocturnal hypoglycaemia 50 neovascularization 50 ALT flares 50 IgG antibody 50 lipid parameters 50 Hypotension 50 Neutrophil 50 DOXIL 50 peripheral neuropathy disabling 50 primary hypercholesterolemia 50 PTH secretion 50 alpha1 50 PlGF 50 molecular weight heparins 50 cobicistat 50 osteoclastic 50 HoFH 50 CRp 50 CD4 + CD8 + 50 recurrent ischemia 50 hepatic 50 pulmonary exacerbation 50 anemia thrombocytopenia 50 parathyroid hormone PTH 50 NovoLog ® Mix 50 IFN alfa 50 sustained virological response 50 symptomatic intracranial hemorrhage 50 GnRH agonists 50 remission CR 50 cellularity 50 HbA 1c 50 colorectal adenoma 50 hypersensitivity reaction 50 5FU 50 antimicrobial prophylaxis 50 alfa 2a 50 IU mL 50 etoposide 50 systolic BP 50 QT intervals 50 disease progression 50 #mm Hg 50 solifenacin 50 elevated uric acid 50 prior chemotherapy regimens 50 eosinophils 50 ruptured aneurysms 50 diabetic rats 50 euvolemic 50 deep venous thromboses 50 dopaminergic therapy 50 leucocyte 50 zoledronic acid 50 detectable HCV RNA 50 protease inhibitor PI 50 VELCADE melphalan 50 HBeAg positive patients 50 serum BDNF 50 degarelix 50 Viral load 50 receiving APTIVUS r 50 angiotensin converting enzyme inhibitors 50 EDARBI 50 anemia hemoglobin 50 fluid overload 50 frataxin 50 severe renal impairment 50 heavily pretreated 50 intact parathyroid hormone 50 albumin excretion rate 50 mg TID 50 prostate cancer CRPC 50 oral FTY# 50 bacteriuria 50 baseline Hb 50 WT1 50 EpCAM expression 50 peginterferon alfa 2a 50 clusterin 50 myeloablative 50 graft dysfunction 50 hematological toxicity 50 apoB 50 E selectin 50 hour bronchodilation 50 pegylated interferon 50 platelet inhibitor 50 myocardial necrosis 50 thromboembolic 50 allogeneic SCT 50 adrenal insufficiency 50 hemoglobin A1c levels 50 S/GSK# 50 cisplatin chemotherapy 50 left ventricular hypertrophy 50 clinically relevant 50 ACR# response 50 glucocorticoid 50 agonist induced 50 purpura 50 serum IgG 50 QTc interval 50 binary restenosis 50 HER2 expression 50 NATRECOR R 50 euthyroid 50 Hematologic 50 mitomycin C 50 ventricular dilatation 50 subclinical hypothyroidism 50 generalized edema 50 recurrent genital herpes 50 malignant transformation 50 HCV replication 50 CANCIDAS 50 leukemic 50 renal impairment 50 T1DM 50 UACR 50 thrombocytopenia neutropenia 50 log# copies mL 50 mg qd 50 entecavir 50 quetiapine XR 50 interferon ribavirin 50 gastric carcinoma 50 ribavirin RBV 49 CFTR protein 49 mm3 49 fibrinogen 49 CK # plasma concentrations 49 cerebrospinal fluid 49 busulfan 49 myocardial ischemia 49 GVHD 49 Durezol

Back to home page